Family History, Reproductive, and Lifestyle Risk Factors for Fibroadenoma and Breast Cancer

JNCI Cancer Spectrum
Jingmei LiKamila Czene

Abstract

To understand which breast cancer (BC) risk factors also increase the risk of fibroadenoma and investigate whether these factors have the same effect in BC patients with previous fibroadenoma. Using multistate survival analysis on a large dataset (n = 58 322), we examined the effects of BC risk factors on transitions between three states: event-free, biopsy-confirmed fibroadenoma, and BC. Hazard ratios and corresponding 95% confidence intervals associated with covariate effects were estimated. Median follow-up time was 25.3 years. The mean ages at diagnosis of fibroadenoma and BC were 42.6 and 48.3 years, respectively. Participant characteristics known to increase the risk of BC were found to increase the risk of fibroadenoma (family history of BC and higher education). Participant characteristics known to confer protective effects for BC (older age at menarche, more children, and larger childhood body size) were found to reduce fibroadenoma risk. The effect sizes associated with the direct transitions from event-free to fibroadenoma and BC were generally not different for the covariates tested. Age at fibroadenoma diagnosis was associated with the transition from fibroadenoma to BC (hazard ratioper year increase = 1.07 [95% co...Continue Reading

References

Sep 1, 1978·International Journal of Epidemiology·P E SartwellJ A Tonascia
Nov 1, 1989·World Journal of Surgery·D M Dent, P J Cant
Apr 1, 1985·Journal of the Royal Society of Health·A A Kubba
Jul 1, 1984·American Journal of Epidemiology·F ParazziniG Tognoni
Jul 7, 1994·The New England Journal of Medicine·W D DupontP A Schuyler
Jan 1, 1997·American Journal of Epidemiology·E L KornD Midthune
Jun 12, 1998·The Australian and New Zealand Journal of Surgery·L FoxcroftC Hirst
Oct 1, 1998·Journal of General Internal Medicine·R GreenbergO Kaplan
Mar 12, 1999·Japanese Journal of Clinical Oncology·H TakeiY Morishita
Apr 2, 2004·Statistics in Medicine·Jonathan TyrerJack Cuzick
Jul 22, 2005·The New England Journal of Medicine·Lynn C HartmannDaniel W Visscher
Dec 21, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Heather J BaerGraham A Colditz
May 25, 2006·The Oncologist·Merih Guray, Aysegul A Sahin
Jul 19, 2006·Biometrical Journal. Biometrische Zeitschrift·Hein PutterCornelis J H van de Velde
Sep 13, 2007·Breast Cancer Research and Treatment·Stephanie A Navarro Silvera, Thomas E Rohan
Mar 19, 2008·Cancer Causes & Control : CCC·Tsogzolmaa DorjgochooXiao Ou Shu
Apr 1, 2008·Clinical Radiology·G E C Smith, P Burrows
Jun 6, 2008·American Journal of Epidemiology·Lisbeth BertelsenJørgen H Olsen
Jun 20, 2008·Statistical Methods in Medical Research·Luís Meira-MachadoPer K Andersen
Sep 4, 2008·Acta Oncologica·Lotti BarlowMats Talbäck
Mar 17, 2010·Computer Methods and Programs in Biomedicine·Liesbeth C de WreedeHein Putter
Jun 15, 2010·Human Reproduction Update·D CibulaL Dusek
Mar 22, 2012·Breast Cancer Research and Treatment·C M G Keyzer-DekkerA F W van der Steeg
Nov 29, 2012·Irish Journal of Medical Science·A C O'NeillS McNally
Apr 26, 2013·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·A Lindsay Frazier, Shoshana M Rosenberg
Jun 22, 2013·BMC Medical Research Methodology·Carolina Meier-Hirmer, Martin Schumacher
Feb 1, 2013·Seminars in Plastic Surgery·Felecia Cerrato, Brian I Labow
Apr 16, 2015·PloS One·Christine EulenburgKarl Wegscheider
Aug 15, 2015·Annals of the Royal College of Surgeons of England·D YueD Ravichandran
Aug 19, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey A TiceKarla Kerlikowske
Feb 10, 2017·International Journal of Epidemiology·Marike GabrielsonPer Hall
Feb 17, 2017·Clinical Epidemiology·Simon JarrickJonas F Ludvigsson

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies

Software Mentioned

mstate
lmtest
FORTE
R
SymPathy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.